179 related articles for article (PubMed ID: 36732416)
1. Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice.
Liu C; Song Z; Li Z; Boon MR; Schönke M; Rensen PCN; Wang Y
Int J Obes (Lond); 2023 Mar; 47(3):236-243. PubMed ID: 36732416
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
[TBL] [Abstract][Full Text] [Related]
4. Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathway.
Ying Z; van Eenige R; Beerepoot R; Boon MR; Kloosterhuis NJ; van de Sluis B; Bartelt A; Rensen PCN; Kooijman S
Pharmacol Res; 2023 Jan; 187():106634. PubMed ID: 36574856
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
Zhou E; Li Z; Nakashima H; Choukoud A; Kooijman S; Berbée JFP; Rensen PCN; Wang Y
Pharmacol Res; 2021 May; 167():105524. PubMed ID: 33667684
[TBL] [Abstract][Full Text] [Related]
6. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice.
Ying Z; van Eenige R; Ge X; van Marwijk C; Lambooij JM; Guigas B; Giera M; de Boer JF; Coskun T; Qu H; Wang Y; Boon MR; Rensen PCN; Kooijman S
EBioMedicine; 2023 Jul; 93():104684. PubMed ID: 37379656
[TBL] [Abstract][Full Text] [Related]
7. CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.
Bijland S; van den Berg SA; Voshol PJ; van den Hoek AM; Princen HM; Havekes LM; Rensen PC; Willems van Dijk K
J Lipid Res; 2010 Jan; 51(1):97-102. PubMed ID: 19564641
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
[TBL] [Abstract][Full Text] [Related]
9. A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding.
Paalvast Y; Zhou E; Rozendaal YJW; Wang Y; Gerding A; van Dijk TH; de Boer JF; Rensen PCN; van Dijk KW; Kuivenhoven JA; Bakker BM; van Riel NAW; Groen AK
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432620
[TBL] [Abstract][Full Text] [Related]
10. Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development.
Zhou E; Hoeke G; Li Z; Eibergen AC; Schonk AW; Koehorst M; Boverhof R; Havinga R; Kuipers F; Coskun T; Boon MR; Groen AK; Rensen PCN; Berbée JFP; Wang Y
Cardiovasc Res; 2020 Aug; 116(10):1710-1720. PubMed ID: 31589318
[TBL] [Abstract][Full Text] [Related]
11. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
12. Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.
Pouwer MG; Pieterman EJ; Chang SC; Olsen GW; Caspers MPM; Verschuren L; Jukema JW; Princen HMG
Toxicol Sci; 2019 Apr; 168(2):519-534. PubMed ID: 30657992
[TBL] [Abstract][Full Text] [Related]
13. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
Berbée JF; Boon MR; Khedoe PP; Bartelt A; Schlein C; Worthmann A; Kooijman S; Hoeke G; Mol IM; John C; Jung C; Vazirpanah N; Brouwers LP; Gordts PL; Esko JD; Hiemstra PS; Havekes LM; Scheja L; Heeren J; Rensen PC
Nat Commun; 2015 Mar; 6():6356. PubMed ID: 25754609
[TBL] [Abstract][Full Text] [Related]
14. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
[TBL] [Abstract][Full Text] [Related]
15. Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
Liu C; Li Z; Song Z; Fan X; Shao H; Schönke M; Boon MR; Rensen PCN; Wang Y
Atherosclerosis; 2022 Dec; 362():47-55. PubMed ID: 36347649
[TBL] [Abstract][Full Text] [Related]
16. Aging attenuates diurnal lipid uptake by brown adipose tissue.
In Het Panhuis W; Schönke M; Siebeler R; Afkir S; Baelde R; Pronk ACM; Streefland TCM; Sips HCM; Lalai RA; Rensen PCN; Kooijman S
Aging (Albany NY); 2022 Oct; 14(19):7734-7751. PubMed ID: 36202134
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice.
Zhou E; Li Z; Nakashima H; Liu C; Ying Z; Foks AC; Berbée JFP; van Dijk KW; Rensen PCN; Wang Y
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1474-1486. PubMed ID: 33567866
[TBL] [Abstract][Full Text] [Related]
18. Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia.
Berbée JFP; Mol IM; Milne GL; Pollock E; Hoeke G; Lütjohann D; Monaco C; Rensen PCN; van der Ploeg LHT; Shchepinov MS
Atherosclerosis; 2017 Sep; 264():100-107. PubMed ID: 28655430
[TBL] [Abstract][Full Text] [Related]
19. Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice.
Li Z; Wang Y; van der Sluis RJ; van der Hoorn JW; Princen HM; Van Eck M; Van Berkel TJ; Rensen PC; Hoekstra M
Biochem Pharmacol; 2012 Sep; 84(6):821-9. PubMed ID: 22750059
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
